Viewing StudyNCT02122172



Ignite Creation Date: 2024-05-06 @ 2:47 AM
Last Modification Date: 2024-10-26 @ 11:23 AM
Study NCT ID: NCT02122172
Status: TERMINATED
Last Update Posted: 2024-05-29
First Post: 2014-04-22

Brief Title: Afatinib in Advanced Refractory Urothelial Cancer
Sponsor: University of Chicago
Organization: University of Chicago

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09-13
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-04
Primary Completion Date Type: ACTUAL
Completion Date: 2024-04-04
Completion Date Type: ACTUAL
First Submit Date: 2014-04-22
First Submit QC Date: April 23 2014
Study First Post Date: 2014-04-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-28
Last Update Post Date: 2024-05-29
Last Update Post Date Type: ACTUAL